Conatumumab: a novel monoclonal antibody against death receptor 5 for the treatment of advanced malignancies in adults

2011 ◽  
Vol 11 (11) ◽  
pp. 1519-1524 ◽  
Author(s):  
Madhuri Bajaj ◽  
Elisabeth I Heath
Keyword(s):  
Monoclonal Antibody ◽  
Death Receptor ◽  
Death Receptor 5 ◽  
Advanced Malignancies

scholarly journals Structural basis of LaDR5, a novel agonistic anti-death receptor 5 (DR5) monoclonal antibody, to inhibit DR5/TRAIL complex formation

2012 ◽  
Vol 13 (1) ◽  
pp. 40
Author(s):  
Chunxia Qiao ◽  
Meiyun Hu ◽  
Leiming Guo ◽  
Ming Lv ◽  
Zhou Lin ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Complex Formation ◽  
Death Receptor ◽  
Structural Basis ◽  
Death Receptor 5

scholarly journals Phase I Trial of Weekly Tigatuzumab, an Agonistic Humanized Monoclonal Antibody Targeting Death Receptor 5 (DR5)

2010 ◽  
Vol 25 (1) ◽  
pp. 13-19 ◽  
Author(s):  
Andres Forero-Torres ◽  
Jatin Shah ◽  
Tina Wood ◽  
James Posey ◽  
Ronda Carlisle ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
Phase I Trial ◽  
Death Receptor ◽  
Death Receptor 5 ◽  
Humanized Monoclonal Antibody ◽  
Antibody Targeting

240 Molecular imaging of Death Receptor 5 (DR5) occupancy in-vivo by humanized monoclonal antibody CS-1008

2010 ◽  
Vol 8 (7) ◽  
pp. 78
Author(s):  
A.M. Scott ◽  
F.T. Lee ◽  
G.C. Cartwright ◽  
G.J. O'Keefe ◽  
R.A. Beckman ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Molecular Imaging ◽  
Death Receptor ◽  
Death Receptor 5 ◽  
Humanized Monoclonal Antibody
Sign in / Sign up

Export Citation Format

Share Document